Transce3nd’s Organigram Holdings OGI Stock Holding History

Transce3nd’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15	Closed	-$20	–	818
2025 Q2	$20	Hold	15	–	–	﹤0.01%	1207
2025 Q1	$15	Hold	15	–	–	﹤0.01%	1180
2024 Q4	$24	Buy	+15	New	+$24	﹤0.01%	1547

Other funds holding OGI

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Transce3nd's OGI Position: Q3 2025 in Review

Transce3nd sold out of Organigram Holdings (OGI) in Q3 2025, closing a stake of 15 shares — an estimated $20 sold.

Transce3nd first reported a position in OGI in Q4 2024 and held it in 3 quarters. The position peaked at $24 in Q4 2024. 67 funds tracked by Wall St. Rank hold OGI as of Q3 2025.

Transce3nd reported no remaining Organigram Holdings position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 15 Organigram Holdings shares in Q3 2025, an estimated $20.
Transce3nd first reported a position in Organigram Holdings in Q4 2024 and held it in 3 quarters.
Transce3nd's Organigram Holdings position peaked at $24 in Q4 2024.
67 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.